TRIMAS CORP (TRS) Fundamental Analysis & Valuation

NASDAQ:TRS • US8962152091

Current stock price

39.085 USD
+0.23 (+0.6%)
Last:

This TRS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

5

1. TRS Profitability Analysis

1.1 Basic Checks

  • TRS had positive earnings in the past year.
  • In the past year TRS had a positive cash flow from operations.
  • In the past 5 years TRS has always been profitable.
  • In the past 5 years TRS always reported a positive cash flow from operatings.
TRS Yearly Net Income VS EBIT VS OCF VS FCFTRS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • TRS has a Return On Assets (3.07%) which is comparable to the rest of the industry.
  • TRS has a Return On Equity (6.08%) which is in line with its industry peers.
  • TRS has a Return On Invested Capital (5.18%) which is in line with its industry peers.
  • The Average Return On Invested Capital over the past 3 years for TRS is significantly below the industry average of 7.18%.
  • The 3 year average ROIC (1.88%) for TRS is below the current ROIC(5.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.07%
ROE 6.08%
ROIC 5.18%
ROA(3y)4.31%
ROA(5y)4.48%
ROE(3y)8.86%
ROE(5y)9.16%
ROIC(3y)1.88%
ROIC(5y)3.55%
TRS Yearly ROA, ROE, ROICTRS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10

1.3 Margins

  • TRS has a Profit Margin (4.35%) which is in line with its industry peers.
  • TRS's Profit Margin has improved in the last couple of years.
  • With a Operating Margin value of 8.11%, TRS perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
  • In the last couple of years the Operating Margin of TRS has declined.
  • Looking at the Gross Margin, with a value of 23.05%, TRS is in the better half of the industry, outperforming 68.18% of the companies in the same industry.
  • TRS's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 8.11%
PM (TTM) 4.35%
GM 23.05%
OM growth 3Y-44.28%
OM growth 5Y-23.66%
PM growth 3Y35.43%
PM growth 5YN/A
GM growth 3Y-3.6%
GM growth 5Y-1.98%
TRS Yearly Profit, Operating, Gross MarginsTRS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

5

2. TRS Health Analysis

2.1 Basic Checks

  • TRS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, TRS has less shares outstanding
  • TRS has less shares outstanding than it did 5 years ago.
  • The debt/assets ratio for TRS is higher compared to a year ago.
TRS Yearly Shares OutstandingTRS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
TRS Yearly Total Debt VS Total AssetsTRS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B

2.2 Solvency

  • An Altman-Z score of 2.41 indicates that TRS is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • TRS has a better Altman-Z score (2.41) than 63.64% of its industry peers.
  • TRS has a debt to FCF ratio of 9.21. This is a negative value and a sign of low solvency as TRS would need 9.21 years to pay back of all of its debts.
  • The Debt to FCF ratio of TRS (9.21) is comparable to the rest of the industry.
  • TRS has a Debt/Equity ratio of 0.56. This is a neutral value indicating TRS is somewhat dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.56, TRS is doing good in the industry, outperforming 72.73% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 9.21
Altman-Z 2.41
ROIC/WACC0.66
WACC7.84%
TRS Yearly LT Debt VS Equity VS FCFTRS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.3 Liquidity

  • TRS has a Current Ratio of 2.68. This indicates that TRS is financially healthy and has no problem in meeting its short term obligations.
  • TRS has a better Current ratio (2.68) than 86.36% of its industry peers.
  • TRS has a Quick Ratio of 1.42. This is a normal value and indicates that TRS is financially healthy and should not expect problems in meeting its short term obligations.
  • TRS has a better Quick ratio (1.42) than 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 2.68
Quick Ratio 1.42
TRS Yearly Current Assets VS Current LiabilitesTRS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2

3. TRS Growth Analysis

3.1 Past

  • TRS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.30%, which is quite impressive.
  • TRS shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.65% yearly.
  • TRS shows a small growth in Revenue. In the last year, the Revenue has grown by 2.37%.
  • Measured over the past years, TRS shows a decrease in Revenue. The Revenue has been decreasing by -3.46% on average per year.
EPS 1Y (TTM)25.3%
EPS 3Y-0.63%
EPS 5Y5.65%
EPS Q2Q%-6.98%
Revenue 1Y (TTM)2.37%
Revenue growth 3Y-9.93%
Revenue growth 5Y-3.46%
Sales Q2Q%12.46%

3.2 Future

  • Based on estimates for the next years, TRS will show a small growth in Earnings Per Share. The EPS will grow by 0.50% on average per year.
  • TRS is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -13.02% yearly.
EPS Next Y-23.69%
EPS Next 2Y0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-27.44%
Revenue Next 2Y-13.02%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
TRS Yearly Revenue VS EstimatesTRS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
TRS Yearly EPS VS EstimatesTRS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2

1

4. TRS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 18.79, TRS is valued on the expensive side.
  • The rest of the industry has a similar Price/Earnings ratio as TRS.
  • When comparing the Price/Earnings ratio of TRS to the average of the S&P500 Index (27.18), we can say TRS is valued slightly cheaper.
  • The Price/Forward Earnings ratio is 24.62, which indicates a rather expensive current valuation of TRS.
  • TRS's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. TRS is more expensive than 77.27% of the companies in the same industry.
  • TRS's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 37.96.
Industry RankSector Rank
PE 18.79
Fwd PE 24.62
TRS Price Earnings VS Forward Price EarningsTRS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, TRS is valued a bit more expensive than the industry average as 77.27% of the companies are valued more cheaply.
  • TRS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. TRS is more expensive than 68.18% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.31
EV/EBITDA 12.23
TRS Per share dataTRS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.32
EPS Next 2Y0.5%
EPS Next 3YN/A

3

5. TRS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.41%, TRS is not a good candidate for dividend investing.
  • TRS's Dividend Yield is slightly below the industry average, which is at 2.50.
  • With a Dividend Yield of 0.41, TRS pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.41%

5.2 History

  • TRS has been paying a dividend for over 5 years, so it has already some track record.
  • TRS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
TRS Yearly Dividends per shareTRS Yearly Dividends per shareYearly Dividends per share 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • TRS pays out 14.97% of its income as dividend. This is a sustainable payout ratio.
DP14.97%
EPS Next 2Y0.5%
EPS Next 3YN/A
TRS Yearly Income VS Free CF VS DividendTRS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M
TRS Dividend Payout.TRS Dividend Payout, showing the Payout Ratio.TRS Dividend Payout.PayoutRetained Earnings

TRS Fundamentals: All Metrics, Ratios and Statistics

TRIMAS CORP

NASDAQ:TRS (4/14/2026, 1:11:57 PM)

39.085

+0.23 (+0.6%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryContainers & Packaging
Earnings (Last)02-26
Earnings (Next)04-30
Inst Owners103.18%
Inst Owner Change-0.01%
Ins Owners6.31%
Ins Owner Change0.47%
Market Cap1.43B
Revenue(TTM)645.72M
Net Income(TTM)44.08M
Analysts80
Price Target45.9 (17.44%)
Short Float %15.69%
Short Ratio8.82
Dividend
Industry RankSector Rank
Dividend Yield 0.41%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP14.97%
Div Incr Years0
Div Non Decr Years4
Ex-Date02-27
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.37%
Min EPS beat(2)7.18%
Max EPS beat(2)25.56%
EPS beat(4)3
Avg EPS beat(4)9%
Min EPS beat(4)-10.46%
Max EPS beat(4)25.56%
EPS beat(8)4
Avg EPS beat(8)-3.16%
EPS beat(12)6
Avg EPS beat(12)-1.31%
EPS beat(16)8
Avg EPS beat(16)-2.95%
Revenue beat(2)2
Avg Revenue beat(2)5.02%
Min Revenue beat(2)1.73%
Max Revenue beat(2)8.31%
Revenue beat(4)3
Avg Revenue beat(4)2.87%
Min Revenue beat(4)-0.21%
Max Revenue beat(4)8.31%
Revenue beat(8)4
Avg Revenue beat(8)-0.97%
Revenue beat(12)5
Avg Revenue beat(12)-2.16%
Revenue beat(16)5
Avg Revenue beat(16)-2.87%
PT rev (1m)8.43%
PT rev (3m)8.43%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-99.52%
EPS NY rev (1m)14.46%
EPS NY rev (3m)29.02%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-39.44%
Revenue NY rev (1m)1.27%
Revenue NY rev (3m)-5.47%
Valuation
Industry RankSector Rank
PE 18.79
Fwd PE 24.62
P/S 1.41
P/FCF 32.31
P/OCF 13.92
P/B 1.98
P/tB 7.98
EV/EBITDA 12.23
EPS(TTM)2.08
EY5.32%
EPS(NY)1.59
Fwd EY4.06%
FCF(TTM)1.21
FCFY3.09%
OCF(TTM)2.81
OCFY7.18%
SpS27.63
BVpS19.76
TBVpS4.9
PEG (NY)N/A
PEG (5Y)3.32
Graham Number30.41
Profitability
Industry RankSector Rank
ROA 3.07%
ROE 6.08%
ROCE 6.56%
ROIC 5.18%
ROICexc 5.32%
ROICexgc 9.62%
OM 8.11%
PM (TTM) 4.35%
GM 23.05%
FCFM 4.38%
ROA(3y)4.31%
ROA(5y)4.48%
ROE(3y)8.86%
ROE(5y)9.16%
ROIC(3y)1.88%
ROIC(5y)3.55%
ROICexc(3y)1.93%
ROICexc(5y)3.86%
ROICexgc(3y)3.53%
ROICexgc(5y)7.56%
ROCE(3y)2.38%
ROCE(5y)4.49%
ROICexgc growth 3Y-57.99%
ROICexgc growth 5Y-35.13%
ROICexc growth 3Y-52.88%
ROICexc growth 5Y-30%
OM growth 3Y-44.28%
OM growth 5Y-23.66%
PM growth 3Y35.43%
PM growth 5YN/A
GM growth 3Y-3.6%
GM growth 5Y-1.98%
F-Score9
Asset Turnover0.71
Health
Industry RankSector Rank
Debt/Equity 0.56
Debt/FCF 9.21
Debt/EBITDA 2.77
Cap/Depr 90.13%
Cap/Sales 5.78%
Interest Coverage 4.37
Cash Conversion 69.96%
Profit Quality 100.68%
Current Ratio 2.68
Quick Ratio 1.42
Altman-Z 2.41
F-Score9
WACC7.84%
ROIC/WACC0.66
Cap/Depr(3y)85.79%
Cap/Depr(5y)85.63%
Cap/Sales(3y)7.96%
Cap/Sales(5y)6.87%
Profit Quality(3y)64.85%
Profit Quality(5y)78.05%
High Growth Momentum
Growth
EPS 1Y (TTM)25.3%
EPS 3Y-0.63%
EPS 5Y5.65%
EPS Q2Q%-6.98%
EPS Next Y-23.69%
EPS Next 2Y0.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.37%
Revenue growth 3Y-9.93%
Revenue growth 5Y-3.46%
Sales Q2Q%12.46%
Revenue Next Year-27.44%
Revenue Next 2Y-13.02%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y51.02%
EBIT growth 3Y-49.82%
EBIT growth 5Y-26.3%
EBIT Next Year-7.18%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y270.14%
FCF growth 3Y37.47%
FCF growth 5Y-4.48%
OCF growth 1Y53.15%
OCF growth 3Y17.39%
OCF growth 5Y-1.61%

TRIMAS CORP / TRS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of TRIMAS CORP (TRS) stock?

ChartMill assigns a fundamental rating of 4 / 10 to TRS.


What is the valuation status for TRS stock?

ChartMill assigns a valuation rating of 1 / 10 to TRIMAS CORP (TRS). This can be considered as Overvalued.


What is the profitability of TRS stock?

TRIMAS CORP (TRS) has a profitability rating of 5 / 10.


Can you provide the financial health for TRS stock?

The financial health rating of TRIMAS CORP (TRS) is 5 / 10.


What is the earnings growth outlook for TRIMAS CORP?

The Earnings per Share (EPS) of TRIMAS CORP (TRS) is expected to decline by -23.69% in the next year.